Atomistic De-novo Inhibitor Generation-Guided Drug Repurposing for SARS-CoV-2 Spike Protein with Free-Energy Validation by Well-Tempered Metadynamics.
Advancement in predicting interactions between drugs used to treat psoriasis and its comorbidities by integrating molecular and clinical resources.
Hydrogen Sulfide Metabolism and Pulmonary Hypertension.
Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma.
DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-inflammatory agents for COVID-19.
Interactions between cardiology and oncology drugs in precision cardio-oncology.
Drug target gene-based analyses of drug repositionability in rare and intractable diseases.
Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes.
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.
Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.